Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Terminated 1Completed 1

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Thoracic 2

Conditions

Smoking Cessation 3Smoking 2Neoplasms 2Lung Neoplasms 2Alcohol Drinking 2Urinary Bladder Neoplasms 1Smokers 1Postoperative Complications 1Cigarette Smoking 1Cigarette Smoker 1Carcinoma, Non-Small-Cell Lung 1Cancer Free Women 1Adenocarcinoma of Lung 1

Interventions

Carboplatin 177Radiotherapy 139Cisplatin 110Pemetrexed 102Docetaxel 93Paclitaxel 92Gemcitabine 78Erlotinib Hydrochloride 73Magnetic Resonance Spectroscopy 72Radiosurgery 67Bevacizumab 65pembrolizumab 64Etoposide 60Blood Specimen Collection 60durvalumab 53Specimen Handling 48Nivolumab 48Surveys and Questionnaires 47Drug Therapy 41Standard of Care 35Radiation 33osimertinib 32atezolizumab 32Surgical Procedures, Operative 30Topotecan 29Irinotecan 29Gefitinib 29Educational Status 29Early Intervention, Educational 29Biopsy 28

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Lung Neoplasms × Smoking Devices × Clear all
NCT05304390 2024-12-02

A Tailored Screening and Smoking Cessation Program for the LGBTQ Community of Seattle

Fred Hutchinson Cancer Center

Phase NA Terminated
53 enrolled
Thoracic

Lung Neoplasms

NCT03642041 2018-08-22

Study of Smoking Trajectory in Newly Diagnosis Lung Cancer Patients

National Defense Medical Center, Taiwan

Completed
406 enrolled
Thoracic

Cigarette Smoking, Lung Neoplasms, Smoking

Data powered by HemOnc (CC BY 4.0) Colophon âš¡